International Stem Cell Corp (ISCO): Free Cash Flow
-$35.0K
Year ended 2025-12-31
$333.0K
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$35.0K | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$153.0K | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $849.0K | +156.5% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $331.0K | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$1.32M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$369.0K | n/m | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$1.56M | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$1.27M | n/m | 2020-06-01, From 2018-01-01 |
| 2017-12-31 | -$2.25M | n/m | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | -$4.43M | n/m | 2018-04-09, From 2016-01-01 |
| 2015-12-31 | -$4.16M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$6.71M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$5.80M | n/a | 2015-03-30, From 2013-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$35.0K | n/m |
| BioAge Labs, Inc. (BIOA) | 2025-12-31 | -$82.35M | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | -$89.83M | n/m |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | -$83.28M | n/m |
| Zenas BioPharma, Inc. (ZBIO) | 2025-12-31 | -$172.35M | n/m |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | -$758.56M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | -$47.22M | n/m |
| Bolt Biotherapeutics, Inc. (BOLT) | 2025-12-31 | -$39.92M | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$15.67M | n/m |
Compare ISCO, BIOA, PGEN, JANX side by side · Screen every company in Pharmaceutical Preparations ↗